Protara Therapeutics, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Protara Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $73.57M.
- Protara Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2020-03-31 was $1.87M.
- Protara Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2018-09-30 was $2.85M.
- Protara Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2020 was $11.09M.
- Protara Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2018 was $2.85M, a 121.43% increase from fiscal 2017.
- Protara Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2017 was $1.29M.
- Protara Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2014 was $62.48M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2020-12-31 | $11.09M 10-K · filed 2021-03-11 | |
| 2020-09-30 | $73.57M 10-Q · filed 2020-11-12 | |
| 2020-03-31 | $1.87M 10-Q · filed 2020-11-12 | |
| 2018-12-31 | $2.85M 10-K · filed 2020-03-20 | |
| 2018-09-30 | $2.85M 10-Q · filed 2019-10-31 | |
| 2017-12-31 | $1.29M 10-K · filed 2019-03-13 | |
| 2014-12-31 | $62.48M 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |